News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
694,696 Results
Type
Article (44453)
Company Profile (225)
Press Release (650002)
Multimedia
Podcasts (146)
Webinars (19)
Section
Business (190493)
Career Advice (2862)
Deals (35249)
Drug Delivery (134)
Drug Development (79547)
Employer Resources (169)
FDA (16547)
Job Trends (15625)
News (330411)
Policy (32293)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2759)
Academic (1)
Accelerated approval (31)
Adcomms (33)
Allergies (146)
Alliances (47680)
ALS (180)
Alzheimer's disease (1742)
Antibody-drug conjugate (ADC) (324)
Approvals (16796)
Artificial intelligence (562)
Autoimmune disease (164)
Automation (36)
Bankruptcy (329)
Best Places to Work (12262)
BIOSECURE Act (21)
Biosimilars (197)
Biotechnology (115)
Bladder cancer (161)
Brain cancer (60)
Breast cancer (652)
Cancer (4927)
Cardiovascular disease (431)
Career advice (2407)
Career pathing (40)
CAR-T (292)
CDC (48)
Celiac Disease (2)
Cell therapy (780)
Cervical cancer (35)
Clinical research (68106)
Collaboration (1809)
Company closure (4)
Compensation (1166)
Complete response letters (66)
COVID-19 (2720)
CRISPR (98)
C-suite (876)
Cystic fibrosis (153)
Data (6312)
Decentralized trials (2)
Denatured (41)
Depression (140)
Diabetes (517)
Diagnostics (7003)
Digital health (46)
Diversity (11)
Diversity, equity & inclusion (40)
Drug discovery (255)
Drug pricing (220)
Drug shortages (34)
Duchenne muscular dystrophy (231)
Earnings (79142)
Editorial (64)
Employer branding (21)
Employer resources (152)
Events (115173)
Executive appointments (1026)
FDA (19729)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (9)
Frontotemporal dementia (24)
Funding (1505)
Gene editing (210)
Generative AI (47)
Gene therapy (627)
GLP-1 (1054)
Government (4629)
Grass and pollen (7)
Guidances (383)
Healthcare (20133)
HIV (58)
Huntington's disease (45)
IgA nephropathy (86)
Immunology and inflammation (270)
Immuno-oncology (58)
Indications (105)
Infectious disease (2996)
Inflammatory bowel disease (200)
Inflation Reduction Act (14)
Influenza (111)
Intellectual property (250)
Interviews (548)
IPO (16819)
IRA (57)
Job creations (3723)
Job search strategy (1979)
JPM (65)
Kidney cancer (17)
Labor market (77)
Layoffs (578)
Leadership (39)
Legal (7588)
Liver cancer (85)
Longevity (14)
Lung cancer (659)
Lymphoma (377)
Machine learning (44)
Management (64)
Manufacturing (825)
MASH (172)
Medical device (14489)
Medtech (14545)
Mergers & acquisitions (19566)
Metabolic disorders (1353)
Multiple sclerosis (165)
NASH (21)
Neurodegenerative disease (339)
Neuropsychiatric disorders (95)
Neuroscience (3027)
Neurotech (1)
NextGen: Class of 2026 (6951)
Non-profit (4887)
Now hiring (62)
Obesity (654)
Opinion (317)
Ovarian cancer (167)
Pain (218)
Pancreatic cancer (226)
Parkinson's disease (298)
Partnered (32)
Patents (505)
Patient recruitment (495)
Peanut (59)
People (57737)
Pharmaceutical (89)
Pharmacy benefit managers (33)
Phase 1 (21254)
Phase 2 (30051)
Phase 3 (22508)
Pipeline (5236)
Policy (317)
Postmarket research (2310)
Preclinical (8825)
Press Release (62)
Prostate cancer (245)
Psychedelics (51)
Radiopharmaceuticals (295)
Rare diseases (892)
Real estate (5702)
Recruiting (71)
Regulatory (24598)
Reports (34)
Research institute (2565)
Resumes & cover letters (457)
Rett syndrome (27)
RNA editing (17)
RSV (81)
Schizophrenia (156)
Series A (248)
Series B (193)
Service/supplier (11)
Sickle cell disease (104)
Special edition (25)
Spinal muscular atrophy (165)
Sponsored (38)
Startups (3448)
State (2)
Stomach cancer (15)
Supply chain (111)
Tariffs (100)
The Weekly (103)
Vaccines (983)
Venture capital (93)
Weight loss (443)
Women's health (81)
Worklife (21)
Date
Today (85)
Last 7 days (601)
Last 30 days (2155)
Last 365 days (31432)
2026 (3087)
2025 (31804)
2024 (36775)
2023 (41797)
2022 (52921)
2021 (57599)
2020 (56250)
2019 (49488)
2018 (37384)
2017 (33626)
2016 (32398)
2015 (37650)
2014 (28384)
2013 (23061)
2012 (24595)
2011 (25183)
2010 (22424)
Location
Africa (882)
Alabama (91)
Alaska (7)
Arizona (251)
Arkansas (13)
Asia (42472)
Australia (7114)
California (11435)
Canada (3306)
China (1159)
Colorado (486)
Connecticut (495)
Delaware (342)
Europe (94124)
Florida (1698)
Georgia (372)
Hawaii (3)
Idaho (62)
Illinois (894)
India (65)
Indiana (543)
Iowa (22)
Japan (433)
Kansas (124)
Kentucky (42)
Louisiana (26)
Maine (83)
Maryland (1395)
Massachusetts (8403)
Michigan (345)
Minnesota (642)
Mississippi (6)
Missouri (139)
Montana (34)
Nebraska (28)
Nevada (127)
New Hampshire (85)
New Jersey (3088)
New Mexico (31)
New York (3030)
North Carolina (1533)
North Dakota (10)
Northern California (5569)
Ohio (348)
Oklahoma (22)
Oregon (45)
Pennsylvania (2302)
Puerto Rico (23)
Rhode Island (48)
South America (1233)
South Carolina (66)
South Dakota (1)
Southern California (4473)
Tennessee (174)
Texas (1783)
United States (41002)
Utah (349)
Vermont (1)
Virginia (280)
Washington D.C. (83)
Washington State (953)
West Virginia (4)
Wisconsin (121)
Wyoming (2)
694,696 Results for "xspray pharma ab".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Nomination Committee Appointed for AGM 2026 in Ascelia Pharma AB
December 22, 2025
·
2 min read
Press Releases
Xspray Pharma Submits XS003 to the FDA – The Company’s Second Product Candidate from the HyNap Platform
August 20, 2025
·
2 min read
Press Releases
Xspray Pharma Signs License Agreement with Handa Therapeutics – to Receive up to Double-Digit Royalty on Handa’s Net Proceeds
August 12, 2025
·
1 min read
FDA Accepts Xspray Pharma’s NDA-resubmission for Dasynoc® – PDUFA Date set to 31 July 2024
Xspray Pharma AB (publ) (Nasdaq Stockholm: XSPRAY): The U.S. Food and Drug Administration (FDA) has accepted the resubmission of Xspray Pharma’s New Drug Application (NDA) for Dasynoc ® , following a Complete Response Letter (CRL) where additional information was requested.
February 12, 2024
·
2 min read
Press Releases
As mental health patients turn to AI chatbots, how can pharma lead the way?
A new report by Bryter released today reveals where pharma can lead as patients turn to (and question) AI tools for mental health.
February 5, 2026
·
1 min read
Xspray Pharma’s XS003 Achieves Superior Bioavailability Milestone, Matching TASIGNA® at Reduced Dosage
Xspray Pharma AB announced that XS003, its amorphous, non-crystalline formulation of nilotinib, has demonstrated bioavailability within the 80-125% range to TASIGNA® following oral administration with significantly lower dose.
November 21, 2023
·
4 min read
Drug pricing
Despite MFN Deals, Drug Pricing Will Dog Pharma Into 2026
Only a handful of the top pharmas have signed Most Favored Nation drug pricing deals with the White House, while smaller biotechs continue to hang in limbo.
January 6, 2026
·
5 min read
·
Annalee Armstrong
Mergers & acquisitions
At JPM26, Policy and Politics Will Loom Large for Pharma as Biotech Sees the Sun
Pharmas will need to provide their latest stance on the Most Favored Nation drug pricing plans, while biotech finally gets a break after a few tough years.
January 9, 2026
·
4 min read
·
Annalee Armstrong
Press Releases
Change in Number of Shares and Votes in Alligator Bioscience AB
February 1, 2026
·
1 min read
Press Releases
Notice To Extraordinary General Meeting In Alzecure Pharma AB
June 16, 2025
·
7 min read
1 of 69,470
Next
